Skip to content

Research and laboratory use only · Not for human, clinical, diagnostic or veterinary use

Specification recordRT10

Retatrutide — 10 mg

Retatrutide is supplied as a lyophilized synthetic peptide in a sealed vial (10 mg per vial). For research and laboratory use only.

Type
Synthetic peptide
Amount
10 mg per vial
Form
Lyophilized powder
Purity
98.74%
Storage
Refrigerate at 2–8 °C (see Storage Instructions)
Verified institutional supply · Ontario

Research Materials,
Documented and Controlled.

Sterigenix supplies professionally presented research materials to verified laboratories, institutions and research businesses. Catalogue pricing and ordering are released only after account verification.

  • Verified accounts only
  • Purchase-order ordering
  • Certificate records available
  • Ontario, Canada
  • Laboratory research supply
  • Documented specifications

A structured supply channel for research institutions, laboratories and research businesses.

Access model

We supply verified organisations only.

Pricing, ordering and documentation are not public. Access is granted per organisation after review, and is not offered to individual consumers.

41catalogue items

  1. 01

    Submit credentials

    Institution or business registration, research licence, and the responsible principal investigator or purchasing officer.

  2. 02

    Documentation review

    Each submission is reviewed against our supply standards. We may request further documentation before a decision.

  3. 03

    Account issued

    Approved accounts receive catalogue pricing, purchase-order ordering, and access to available product documentation.

Catalogue

Analysed and specified

All 41 items
BPC-157 + TB-500 — 20 mg Combination Vial — Lyophilized powder
BB20BPC-157 99.78%; TB-500 98.76%

BPC-157 + TB-500 — 20 mg Combination Vial

BPC-157 + TB-500 is supplied as a lyophilized powder in a sealed vial (BPC-157 10 mg + TB-500 10 mg per vial). For research and laboratory use only.

  • Synthetic peptide combination
  • BPC-157 10 mg + TB-500 10 mg per vial
  • Lyophilized powder
SealedPricing is released to verified accounts only.
Request access
CJC-1295 Without DAC + Ipamorelin — 10 mg Combination Vial — Lyophilized powder
CP10CJC-1295 without DAC 98.46%; Ipamorelin 98.20%

CJC-1295 Without DAC + Ipamorelin — 10 mg Combination Vial

CJC-1295 (without DAC) + Ipamorelin is supplied as a lyophilized powder in a sealed vial (CJC-1295 without DAC 5 mg + Ipamorelin 5 mg per vial). For research and laboratory use only.

  • Synthetic peptide combination
  • CJC-1295 without DAC 5 mg + Ipamorelin 5 mg per vial
  • Lyophilized powder
SealedPricing is released to verified accounts only.
Request access
Glow Blend — 70 mg — Lyophilized powder
BBG70BPC-157 99.05%; GHK-Cu 99.21%; TB-500 99.30%

Glow Blend — 70 mg

Glow Blend is supplied as a lyophilized combination preparation in a sealed vial (70 mg per vial). For research and laboratory use only.

  • Combination preparation
  • 70 mg per vial
  • Lyophilized powder
SealedPricing is released to verified accounts only.
Request access

Standards

Presentation, sourcing and documentation held to one standard.

About Sterigenix
  • Clear product information

    Products are presented with organised descriptions, specifications and supporting information where applicable.

  • Professional supply standards

    Structured product presentation, category organisation and consistent operational standards.

  • Available documentation

    Supporting product documentation and certificate records may be available for select items where applicable.

Research library

Reference notes

All notes

Apply for a verified account

Accounts are issued to organisations, not individuals, and only after documentation review.

Request access